Pfizer's Xeljanz jumps into ulcerative colitis fray with best-case FDA approval
admin 31st May 2018 Uncategorised 0Xeljanz is on a roll. The Pfizer immunology blockbuster scored a big new approval in psoriatic arthritis last year, and now it has won an FDA green light to treat ulcerative colitis. Plus, the approval includes the larger 10-mg dose, despite some internal agency questions about safety.
More: Pfizer's Xeljanz jumps into ulcerative colitis fray with best-case FDA approval
Source: fierce